These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 17895474)
1. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. Haas GP; Delongchamps NB; Jones RF; Chandan V; Serio AM; Vickers AJ; Jumbelic M; Threatte G; Korets R; Lilja H; de la Roza G J Natl Cancer Inst; 2007 Oct; 99(19):1484-9. PubMed ID: 17895474 [TBL] [Abstract][Full Text] [Related]
2. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade. Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706 [TBL] [Abstract][Full Text] [Related]
3. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings. Delatour NL; Mai KT Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923 [TBL] [Abstract][Full Text] [Related]
4. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy. Campos-Fernandes JL; Bastien L; Nicolaiew N; Robert G; Terry S; Vacherot F; Salomon L; Allory Y; Vordos D; Hoznek A; Yiou R; Patard JJ; Abbou CC; de la Taille A Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen. Delongchamps NB; de la Roza G; Chandan V; Jones R; Threatte G; Jumbelic M; Haas GP Prostate Cancer Prostatic Dis; 2009; 12(2):137-42. PubMed ID: 18626509 [TBL] [Abstract][Full Text] [Related]
6. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. Welch HG; Fisher ES; Gottlieb DJ; Barry MJ J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671 [TBL] [Abstract][Full Text] [Related]
7. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme. Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847 [TBL] [Abstract][Full Text] [Related]
8. Anterior apical biopsy: is it useful for prostate cancer detection? Orikasa K; Ito A; Ishidoya S; Saito S; Endo M; Arai Y Int J Urol; 2008 Oct; 15(10):900-4; discussion 904. PubMed ID: 18657203 [TBL] [Abstract][Full Text] [Related]
11. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial. Cohen YC; Liu KS; Heyden NL; Carides AD; Anderson KM; Daifotis AG; Gann PH J Natl Cancer Inst; 2007 Sep; 99(18):1366-74. PubMed ID: 17848668 [TBL] [Abstract][Full Text] [Related]
12. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695 [TBL] [Abstract][Full Text] [Related]
13. Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer. Loeb S; Roehl KA; Thaxton CS; Catalona WJ Urology; 2008 Jul; 72(1):143-7. PubMed ID: 18436287 [TBL] [Abstract][Full Text] [Related]
14. Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled. Herawi M; Kahane H; Cavallo C; Epstein JI J Urol; 2006 Jan; 175(1):121-4. PubMed ID: 16406886 [TBL] [Abstract][Full Text] [Related]
15. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men. Shigemura K; Arakawa S; Yamanaka K; Kataoka N; Yuien K; Fujisawa M Int J Urol; 2007 Oct; 14(10):935-8. PubMed ID: 17880293 [TBL] [Abstract][Full Text] [Related]
16. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance. Nakanishi H; Groskopf J; Fritsche HA; Bhadkamkar V; Blase A; Kumar SV; Davis JW; Troncoso P; Rittenhouse H; Babaian RJ J Urol; 2008 May; 179(5):1804-9; discussion 1809-10. PubMed ID: 18353398 [TBL] [Abstract][Full Text] [Related]
17. High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates. Sajadi KP; Kim T; Terris MK; Brown JA; Lewis RW Urology; 2007 Oct; 70(4):691-5. PubMed ID: 17991539 [TBL] [Abstract][Full Text] [Related]
18. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance. Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909 [TBL] [Abstract][Full Text] [Related]